Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Other Non-Current Liabilities (2023 - 2025)

CG Oncology's Other Non-Current Liabilities history spans 2 years, with the latest figure at $1.7 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities changed N/A year-over-year to $1.7 million; the TTM value through Dec 2025 reached $1.7 million, changed N/A, while the annual FY2025 figure was $1.7 million, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $1.7 million in Q4 2025 per CGON's latest filing, down from $3.8 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.8 million in Q3 2025 to a low of $365000.0 in Q4 2023.